Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Friedman

Showing results (321-330 of 390) with videos related to

Pageof 39
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Randomized, double-blind, placebo-controlled, phase II trial of sorafenib and erlotinib or erlotinib alone in previously treated advanced non-small-cell lung cancerDavid R Spigel, Howard A Burris, F Anthony Greco, et al.
Plos One|February 6, 2014
Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of pediatric solid tumorsMichael L Megison, Lauren A Gillory, Jerry E Stewart, et al.
Oncogene|March 12, 2003
Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding siteTamara N Do, Ramon V Rosal, Lisa Drew, et al.
Translational Oncology|July 31, 2019
UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line XenograftsAdele P Williams, Evan F Garner, Laura L Stafman, et al.
Apoptosis : an International Journal on Programmed Cell Death|August 15, 2015
Polymorphism in apoptotic BAX (-248G>A) gene but not in anti-apoptotic BCL2 (-938C>A) gene and its protein and mRNA expression are associated with cervical intraepithelial neoplasiaAna Teresa G Fernandes, Natália P Rocha, Elena Vendrame, et al.
Scientific Reports|September 19, 2018
Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 ExpressionGregory K Friedman, Joshua D Bernstock, Dongquan Chen, et al.
Human Gene Therapy|July 14, 2020
Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain TumorsJoshua D Bernstock, Asim K Bag, John Fiveash, et al.
Sexual Health|May 6, 2025
Diagnoses of sexually transmissible infections in HIV-serodiscordant male couples in Australia, Brazil and ThailandJames Gray, Fengyi Jin, Nittaya Phanuphak, et al.
Frontiers in Cell and Developmental Biology|October 20, 2023
Positioning SUMO as an immunological facilitator of oncolytic viruses for high-grade gliomaParamesh V Karandikar, Lyle Suh, Jakob V E Gerstl, et al.
JCO Precision Oncology|September 11, 2020
Prospective Clinical Validation of the InVisionFirst-Lung Circulating Tumor DNA Assay for Molecular Profiling of Patients With Advanced Nonsquamous Non-Small-Cell Lung CancerMichael A Pritchett, D Ross Camidge, Manu Patel, et al.
Pageof 39

Showing results (321-330 of 390) with videos related to

Sort By:
Pageof 39
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Randomized, double-blind, placebo-controlled, phase II trial of sorafenib and erlotinib or erlotinib alone in previously treated advanced non-small-cell lung cancerDavid R Spigel, Howard A Burris, F Anthony Greco, et al.
Plos One|February 6, 2014
Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of pediatric solid tumorsMichael L Megison, Lauren A Gillory, Jerry E Stewart, et al.
Oncogene|March 12, 2003
Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding siteTamara N Do, Ramon V Rosal, Lisa Drew, et al.
Translational Oncology|July 31, 2019
UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line XenograftsAdele P Williams, Evan F Garner, Laura L Stafman, et al.
Apoptosis : an International Journal on Programmed Cell Death|August 15, 2015
Polymorphism in apoptotic BAX (-248G>A) gene but not in anti-apoptotic BCL2 (-938C>A) gene and its protein and mRNA expression are associated with cervical intraepithelial neoplasiaAna Teresa G Fernandes, Natália P Rocha, Elena Vendrame, et al.
Scientific Reports|September 19, 2018
Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 ExpressionGregory K Friedman, Joshua D Bernstock, Dongquan Chen, et al.
Human Gene Therapy|July 14, 2020
Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain TumorsJoshua D Bernstock, Asim K Bag, John Fiveash, et al.
Sexual Health|May 6, 2025
Diagnoses of sexually transmissible infections in HIV-serodiscordant male couples in Australia, Brazil and ThailandJames Gray, Fengyi Jin, Nittaya Phanuphak, et al.
Frontiers in Cell and Developmental Biology|October 20, 2023
Positioning SUMO as an immunological facilitator of oncolytic viruses for high-grade gliomaParamesh V Karandikar, Lyle Suh, Jakob V E Gerstl, et al.
JCO Precision Oncology|September 11, 2020
Prospective Clinical Validation of the InVisionFirst-Lung Circulating Tumor DNA Assay for Molecular Profiling of Patients With Advanced Nonsquamous Non-Small-Cell Lung CancerMichael A Pritchett, D Ross Camidge, Manu Patel, et al.
Pageof 39